NICE refuses the appeal for Alzheimer's drug treatments

NICE has today (Wednesday 11 October) announced that the appeals lodged by stakeholders against draft guidance on the use of drugs to treat Alzheimer's disease have not been upheld.

Test for Alzheimer's disease

This final guidance from NICE will recommend to the NHS in November that donepezil, galantamine and rivastigmine should only be considered as options for treatment of people with moderate Alzheimer’s disease. Memantine is only recommended as part of clinical studies for people with moderate-severe to severe Alzheimer’s disease.

In 2001 NICE guidance recommended that the Alzheimer’s drugs should be used as a standard treatment. However, a further appraisal in 2005 resulted in NICE stating that the drugs should be restricted as the cost of treating these patients was not supported by the available evidence.

The pharmaceutical manufacturers were asked to present further evidence of the effectiveness of these treatments in patients with mild Alzheimer’s disease.

Andrew Dillon, NICE chief executive, said: ‘Alzheimer’s is a cruel and devastating illness and we realise that today’s announcement will be disappointing to people with Alzheimer’s disease and those who treat and care for them. But we have to be honest and say that based on all the evidence, including data presented by the drug companies themselves, our experts have concluded that these drugs do not make enough difference for us to recommend their use for treating all stages of Alzheimer’s disease.’

Pfizer and Eisai, manufacturers of donepezil, are reported to be considering a judicial review of the decision.

eMIMS links

Alzheimer's dementia

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published


NICE moves CVD advice closer to QOF and updates treatment escalation options

NICE draft guidance on cardiovascular disease backs a new target for lipid levels...

GP surgery sign

GP alert system shows practices under major pressure

General practice has moved up to an 'OPEL 3' pressure rating nationally with two...

Podcast: How making your practice a better place to work can improve patient care

Sheffield GP Dr Ben Allen explains how focusing on staff and improving his practice's...

X-ray sign

Spike in TB cases prompts public health warning

Cases of TB in England have risen by 7% compared with last year, prompting a warning...

COVID-19 vaccine

GPs demand investigation as winter vaccine 'mismanagement' risks patient safety

GP leaders in England have demanded an investigation into 'mismanagement' of this...

Medical centre sign

GP 'engineering' fears as small practice contracts offered on branch-only basis

GP leaders have raised concerns over the 'engineering' of general practice after...